1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Influenza Diagnostics Market- Key Findings, 2020

3. Strategic Imperatives on Global Influenza Diagnostics Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Influenza Diagnostics Companies

4. Global Influenza Diagnostics Market Value Outlook to 2026 Outlook by Test Type

• 4.1 Traditional Diagnostic Test
  • 4.1.1 Rapid Influenza Diagnostic Test (RIDT)
  • 4.1.2 Viral Culture
  • 4.1.3 Direct Fluorescent Antibody (DFA) Test
  • 4.1.4 Serological Assay
• 4.2 Molecular Diagnostic Assay
  • 4.2.1 RT-PCR
  • 4.2.2 Nucleic Acid Sequence-based Amplification (NASBA) Test
  • 4.2.3 Loop-mediated Isothermal Amplification-based Assay (LAMP)
  • 4.2.4 Simple Amplification-based Assay (SAMBA)
  • 4.2.5 Other Molecular Diagnostic Assays

5. Global Influenza Diagnostics Market Value Outlook to 2026 Outlook by End User

• 5.1 Hospital
• 5.2 Research Laboratory
• 5.3 Others

6 Asia Pacific Influenza Diagnostics Market Value Outlook to 2026

• 6.1 Leading Influenza Diagnostics Types contributing to Asia Pacific market
• 6.2 Top Applications contributing to Asia Pacific Influenza Diagnostics
• 6.3 Top countries contributing to Asia Pacific Influenza Diagnostics

7 Europe Influenza Diagnostics Market Value Outlook to 2026

• 7.1 Leading Influenza Diagnostics Types contributing to Europe market
• 7.2 Top Applications contributing to Europe Influenza Diagnostics
• 7.3 Top countries contributing to Europe Influenza Diagnostics

8 North America Influenza Diagnostics Market Value Outlook to 2026

• 8.1 Leading Influenza Diagnostics Types contributing to North America market
• 8.2 Top Applications contributing to North America Influenza Diagnostics
• 8.3 Top countries contributing to North America Influenza Diagnostics

9 South and Central America Influenza Diagnostics Market Value Outlook to 2026

• 9.1 Leading Influenza Diagnostics Types contributing to South and Central America market
• 9.2 Top Applications contributing to South and Central America Influenza Diagnostics
• 9.3 Top countries contributing to South and Central America Influenza Diagnostics

10 Middle East Africa Influenza Diagnostics Market Value Outlook to 2026

• 10.1 Leading Influenza Diagnostics Types contributing to Middle East Africa market
• 10.2 Top Applications contributing to Middle East Africa Influenza Diagnostics
• 10.3 Top countries contributing to Middle East Africa Influenza Diagnostics

11 Business Profiles of Leading Companies

• 11.1 Business Description, SWOT and Financial Analysis of Companies in Influenza Diagnostics market
• 11.2 Abbott
• 11.3 Alere Inc.
• 11.4 Analytik Jena AG
• 11.5 Becton, Dickinson and Company
• 11.6 Coris BioConcept
• 11.7 DiaSorin SpA
• 11.8 F. Hoffmann-La Roche Ltd
• 11.9 Luminex Corporation
• 11.10 Meridian Bioscience Inc.
• 11.11 Quidel Corporation

12 Recent Industry Developments

13 Appendix

• 13.1 OGAnalysis Expertise
• 13.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the Influenza Diagnostics market including the COVID-19 pandemic implications for Influenza Diagnosticss industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Influenza Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Influenza Diagnostics Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Influenza Diagnostics market forecast and Influenza Diagnostics market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Influenza Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Influenza Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Influenza Diagnostics market share in developed countries.

Scope of the research-

Global Influenza Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 By Test Type
Traditional Diagnostic Test
Rapid Influenza Diagnostic Test (RIDT)
Viral Culture
Direct Fluorescent Antibody (DFA) Test
Serological Assay
Molecular Diagnostic Assay
RT-PCR
Nucleic Acid Sequence-based Amplification (NASBA) Test
Loop-mediated Isothermal Amplification-based Assay (LAMP)
Simple Amplification-based Assay (SAMBA)
Other Molecular Diagnostic Assays

Global Influenza Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 By End User including
Hospital
Research Laboratory
Others

Top Companies Operating in Influenza Diagnostics market include- Abbott , Alere Inc.  , Analytik Jena AG , Becton, Dickinson and Company , Coris BioConcept , DiaSorin SpA , F. Hoffmann-La Roche Ltd , Luminex Corporation , 1Meridian Bioscience Inc. , 1Quidel Corporation